CONTRAVIR PHARMACEUTICALS IN's ticker is CTRVXXXX and the CUSIP is 21234W103. A total of 35 filers reported holding CONTRAVIR PHARMACEUTICALS IN in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $8,000 | -11.1% | 14,575 | -2.0% | 0.00% | – |
| Q2 2017 | $9,000 | -70.0% | 14,870 | -11.7% | 0.00% | -100.0% |
| Q1 2017 | $30,000 | +30.4% | 16,840 | -10.2% | 0.00% | – |
| Q4 2016 | $23,000 | +9.5% | 18,751 | -3.1% | 0.00% | – |
| Q3 2016 | $21,000 | -4.5% | 19,342 | -9.9% | 0.00% | – |
| Q2 2016 | $22,000 | -21.4% | 21,460 | -8.5% | 0.00% | -100.0% |
| Q1 2016 | $28,000 | -33.3% | 23,457 | -13.8% | 0.00% | 0.0% |
| Q4 2015 | $42,000 | -33.3% | 27,219 | -9.7% | 0.00% | -50.0% |
| Q3 2015 | $63,000 | – | 30,141 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Anson Funds Management LP | 1,132,737 | $1,399,000 | 0.21% |
| Prospera Financial Services Inc | 177,550 | $215,000 | 0.05% |
| LBA Wealth Management, LLC | 12,000 | $15,000 | 0.01% |
| Cambridge Investment Research Advisors, Inc. | 23,457 | $28,000 | 0.00% |
| TIAA CREF INVESTMENT MANAGEMENT LLC | 313,801 | $866,000 | 0.00% |
| TEACHERS ADVISORS, LLC | 148,551 | $410,000 | 0.00% |
| Balentine LLC | 55 | $0 | 0.00% |
| Capital Advisors, Ltd. LLC | 177 | $0 | 0.00% |
| Vantage Investment Advisors, LLC | 1,150 | $1,000 | 0.00% |
| BLACKROCK ADVISORS LLC | 5,453 | $7,000 | 0.00% |